|
06 Nov 2019 |
Generex Biotechnology Announces First-in-Human Clinical Trial of the ALTuCELL Cellular Therapy Product Altsulin® (Microencapsulated Sertoli Cells)
|
|
05 Nov 2019 |
Enlivex Therapeutics Announces Positive Interim Safety and Efficacy Data From Ongoing Trial of Off-The-Shelf Allocetra in Patients with Severe Sepsis
|
|
05 Nov 2019 |
Unum Therapeutics Announces Strategic Focus on Developing Best-in-Class Cellular Therapies for Solid Tumor Cancers
|
|
01 Nov 2019 |
NexImmune Receives IND Clearance for Phase 1/2 Trial in Acute Myeloid Leukemia / Myelodysplastic Syndrome
|
|
01 Nov 2019 |
Translate Bio Presents MRT5005 Data at the 33rd Annual North American Cystic Fibrosis Conference
|
|
01 Nov 2019 |
Arrowhead Pharmaceuticals Presents Preclinical Data on ARO-ENaC at the North American Cystic Fibrosis Conference
|
|
31 Oct 2019 |
AffyImmune Therapeutics Announces IND Approval for a First-in-Man Trial of Affinity-Tuned CAR-T cells for Patients with Advanced, Refractory Thyroid Cancer
|
|
30 Oct 2019 |
ORYX Announces Positive Phase I/IIa Data for Oncolytic Virus ParvOryx Demonstrating Safety, Anti-tumor Effects, Partial Responses and Prolonged Overall Survival in Metastatic, Inoperable Pancreatic Cancer
|
|
30 Oct 2019 |
Novartis announces AVXS-101 intrathecal study update
|
|
30 Oct 2019 |
First Patient Dosed with Off-the-Shelf UCARTCS1 Product Candidate for Relapsed/Refractory Multiple Myeloma
|
|
26 Oct 2019 |
Xyphos Biosciences and Gladstone Institutes Announce Publication Demonstrating convertibleCAR® Cells and Bispecific Broadly Neutralizing Antibodies Reduce Latent HIV Reservoir
|
|
26 Oct 2019 |
The Parker Institute for Cancer Immunotherapy Partners with Xyphos Biosciences to Develop Universal Programmable CAR-T Cells for Cancer Treatment
|
|
25 Oct 2019 |
Intellia Therapeutics Presents In Vivo and Ex Vivo Data at the 2019 Annual Congress of the European Society of Gene and Cell Therapy (ESGCT)
|
|
24 Oct 2019 |
Selecta Biosciences Presents New Preclinical Data from its Gene Therapy Program at 2019 ESGCT Annual Congress
|
|
24 Oct 2019 |
New Research Study Provides Target Validation for Mateon’s First-in-Class RNA Therapeutic OT101 for the Treatment of Difficult to Treat Forms of Childhood Brain Tumor
|
|
23 Oct 2019 |
Talaris Therapeutics Announces Initiation of Phase 3 Clinical Trial of FCR001 in Living Donor Kidney Transplant Recipients
|
|
22 Oct 2019 |
Orchard Therapeutics Presents Data from OTL-200 in Patients with Metachromatic Leukodystrophy Using Cryopreservation
|
|
22 Oct 2019 |
Rocket Pharmaceuticals Announces Clearance of IND for RP-L301 Gene Therapy for Pyruvate Kinase Deficiency
|
|
21 Oct 2019 |
AGTC Presents Data Demonstrating Efficiency of its AAV Vectors for Ocular Gene Therapy Even in the Presence of Anti-AAV Antibodies
|
|
21 Oct 2019 |
Homology Medicines Presents Data from Investigational PKU and MLD Gene Therapy Programs that Demonstrate Preclinical Proof-of-Concept for Potential One-Time Therapies
|
|
19 Oct 2019 |
IND Application Submission To FDA For Phase 1 Trial Of Genetically Modified Autologous Cell Therapy For HIV Announced by American Gene Technologies
|
|
16 Oct 2019 |
Hope Biosciences Opens First Phase I/II Stem Cell Trial for Brain Injury Treatment
|
|
16 Oct 2019 |
miRagen Announces New Clinical Data Showing MRG-110 Positively Impacted Tissue Repair and New Blood Vessel Growth
|
|
16 Oct 2019 |
NOXXON Enrolls First Patient in the Phase 1/2 Clinical Trial Combining NOX-A12 With Radiotherapy in Newly Diagnosed Brain Cancer
|
|
16 Oct 2019 |
Amarna Therapeutics Raises €10 Million to Progress Lead Development Candidate into Clinical Trials and Appoints a New Supervisory Board
|
